People · Operator
Named in public records as an officer, director or promoter · active 2008–2025 · Biotechnology, Other Health Care, Software / Tech, Other, AI / ML, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Summit Therapeutics Inc. | — | Biotechnology | Series D+ | $569.0M | $2.4B | 2024 |
| Cellanome, Inc. | — | Biotechnology | Series D+ | $213.7M | $2.0B | 2022 |
| Clear Labs, Inc. | — | Biotechnology | Series C | $135.8M | $218.5M | 2018 |
| BaseHealth, Inc. | — | Other Health Care | Series A | $13.6M | $91.7M | 2015 |
| 1health.io Inc.. | — | Software / Tech | Series A | $11.7M | $50.7M | 2023 |
| NextBio | — | Other | Series A | $6.8M | $102.3M | 2008 |
| Tachin.AI Corp | — | AI / ML | Seed | $1.8M | $7.4M | 2025 |
| CellarEye, Inc. | — | Other Technology | Pre-Seed | $955K | $19.5M | 2021 |
Mostafa Ronaghi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mostafa Ronaghi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kazutaka Ohno | 4 | 4 |
| Farzad Naimi | 2 | 5 |
| Mehdi Maghsoodnia | 2 | 4 |
| Neil Hunt | 2 | 4 |
| Saeid Akhtari | 2 | 3 |
| Reza Malek | 2 | 3 |
| Shantanu Agrawal | 2 | 3 |
| Jeff Huber | 1 | 75 |
| Babak Yazdani | 1 | 18 |
| Arman Pahlavan | 1 | 12 |
| Gaurav Garg | 1 | 12 |
| Amir Abolfathi | 1 | 8 |
| Greg Yap | 1 | 8 |
| David Barker | 1 | 7 |
| Rowan Chapman | 1 | 7 |
| Michael Taylor | 1 | 7 |
| David Wurzer | 1 | 7 |
| Robert Booth | 1 | 4 |
| Jim Mellon | 1 | 4 |
| Ming Fang | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.